Cargando…

Drug survival of second biological DMARD therapy in patients with rheumatoid arthritis: a retrospective non-interventional cohort analysis

BACKGROUND: Since persistence to first biological disease modifying anti-rheumatic drugs (bDMARDs) is far from ideal in rheumatoid arthritis (RA) patients, many do receive a second and/or third bDMARD treatment. However, little is known about treatment persistence of the second-line bDMARD and it is...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilke, Thomas, Mueller, Sabrina, Lee, Sze Chim, Majer, Istvan, Heisen, Marieke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540414/
https://www.ncbi.nlm.nih.gov/pubmed/28764705
http://dx.doi.org/10.1186/s12891-017-1684-0